These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10424842)

  • 21. [A cost-effectiveness analysis of strategies for the diagnosis-treatment of Helicobacter pylori-associated peptic ulcer in primary care].
    Badia X; Brosa M; Casado A; Segú L; Alvarez A
    Aten Primaria; 1999 Oct; 24(6):344-51. PubMed ID: 10596225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
    Bock H; Mares A
    Leber Magen Darm; 1996 Sep; 26(5):268. PubMed ID: 9005302
    [No Abstract]   [Full Text] [Related]  

  • 23. Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection.
    Marchildon P; Balaban DH; Sue M; Charles C; Doobay R; Passaretti N; Peacock J; Marshall BJ; Peura DA
    Am J Gastroenterol; 1999 Aug; 94(8):2105-8. PubMed ID: 10445535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
    Labenz J; Stolte M
    Z Gastroenterol; 1999 Jul; 37(7):649-52. PubMed ID: 10458014
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
    Diehl HG
    Leber Magen Darm; 1995 Dec; 25(6):283. PubMed ID: 8577220
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sucralfate in Helicobacter pylori eradication strategies.
    Lam SK; Hu WH; Ching CK
    Scand J Gastroenterol Suppl; 1995; 210():89-91. PubMed ID: 8578217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit study].
    Rollán A; Giancaspero R; Acevedo C; Fuster F; Hola K
    Rev Med Chil; 2000 Apr; 128(4):367-77. PubMed ID: 10962853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Another iron in the H. pylori fire?
    Flemmer M; Oldfield EC
    Am J Gastroenterol; 2000 Oct; 95(10):2983. PubMed ID: 11051384
    [No Abstract]   [Full Text] [Related]  

  • 31. [Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children].
    Kashnikova SN; Shcherbakov PL; Kashnikov VV; Tatarinov PA; Shcherbakova MIu
    Eksp Klin Gastroenterol; 2008; (7):111-8. PubMed ID: 19334454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Best practice' for Helicobacter pylori eradication in the primary care setting.
    Walshe V; O'Morain C; Bennett K; Keeling PW; Barry M
    Ir Med J; 2006 Jan; 99(1):11-2. PubMed ID: 16506682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group.
    Vaira D; Malfertheiner P; Mégraud F; Axon AT; Deltenre M; Gasbarrini G; O'Morain C; Pajares Garcia JM; Quina M; Tytgat GN
    Am J Gastroenterol; 2000 Apr; 95(4):925-9. PubMed ID: 10763939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
    Ofman J; Wallace J; Badamgarav E; Chiou CF; Henning J; Laine L
    Am J Gastroenterol; 2002 Aug; 97(8):1941-50. PubMed ID: 12190158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
    BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-eradication of Helicobacter pylori infection following initial treatment failure: treatment options in clinical practice.
    Moshkowitz M; Halpern Z
    Isr Med Assoc J; 2003 Mar; 5(3):193-4. PubMed ID: 12725141
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infections caused by Helicobacter pylori].
    Stock I; Wiedemann B
    Med Monatsschr Pharm; 1997 Jan; 20(1):2-8. PubMed ID: 9082155
    [No Abstract]   [Full Text] [Related]  

  • 40. Mono and dual therapy for Helicobacter pylori associated gastritis.
    Gill HH; Desai HG; Mehta PR; Ranganathan S; Kalro RH; Murti PK; Prabhu SR
    J Assoc Physicians India; 1991 Oct; 39(10):743-5. PubMed ID: 1816196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.